02nd March 2026
Paul Reid Appointed Independent Chair of IMVO Board
The Irish Medicines Verification Organisation (IMVO) has today announced the appointment of Paul Reid as Independent Chair of its Board. Paul brings extensive leadership experience across the public, private and not-for-profit sectors. Paul previously served as CEO of the Health Service Executive (HSE) from May 2019 to December 2022, where he led Ireland’s health service......READ MORE
22nd December 2025
FMD | In Focus – Christmas issue
The final issue of our newsletter, FMD | In Focus is now available. Topics covered include an update on the FMD impacts of the Windsor Framework, resources from our recent webinars for pharmacies, hospitals, wholesalers and MAHs, and a tribute to our Chairperson, Pat O’Mahony who sadly passed away in August this year. The newsletter......READ MORE
03rd July 2025
FMD | In Focus – summer edition July 2025
The summer issue of our newsletter, FMD | In Focus is now available. Some of the topics covered include an update from our Chief Executive, Leonie Clarke, the recent visit of the Pharmaceutical Group of the European Union (PGEU) to the IMVO offices, a Windsor Framework update, the latest release of the IMVS (Release 16)......READ MORE
02nd December 2024
FMD In | Focus December 2024
The latest issue of our newsletter is now available. This is a themed issue focusing on the Windsor Framework which will take effect on 1 January 2025. In this issue, you will find articles explaining the significance of the Windsor Framework from an FMD perspective, how to avoid problems and where to access training materials......READ MORE
16th May 2024
FMD In | Focus May 2024
The latest issue of our newsletter is now available. Some of the topics include details of our new NMVS Alerts user guide for pharmacies and hospitals, an update on Brexit and the Windsor Framework, information about the latest release of the IMVS. Our colleague Ludvig Möller, Program & Alert Manager from the Swedish NMVO e-VIS,......READ MORE
19th December 2023
FMD In | Focus December 2023
The latest issue of our FMD | In Focus newsletter is now available. Some topics covered in this issue are the new HPRA Q&A on the Windsor Framework and information on the alert management webinars held for pharmacies and hospitals in November. The newsletter can be viewed here. If you want to subscribe to receive......READ MORE
26th October 2023
FMD In | Focus October 2023
The latest issue of our FMD | In Focus newsletter is now available. The topics covered in this issue are about the recent fake Ozempic packs that were identified in the legal supply in the UK and EU, an update on the Windsor Framework, a reminder to pharmacies and hospitals about lending and borrowing packs,......READ MORE
30th May 2022
FMD use and learn period ends in Ireland May 2022
The Falsified Medicines Directive (2011/62/EU) ‘(FMD’) introduced new requirements from February 2019 for safety features on prescription medicines packaging, enabling the packs to be authenticated as genuine prior to supply to patients. FMD has been in a ‘use and learn’ phase in Ireland since February 2019 due, in part, to the impact of Covid-19 and......READ MORE
31st January 2022
Important update about FMD and the end of use and learn
The Safety Features Oversight Group has agreed an updated timetable for the phased ending of the ‘use and learn’ period for FMD in Ireland. The new timings take account of the impact of the Omicron wave of Covid-19 and the decision before Christmas to defer phases 3 and 4 originally scheduled for 10th January. The......READ MORE
22nd December 2021
Important update about FMD and the end of use and learn
The next two phases of the end of use and learn plan for FMD that were scheduled to take effect on 10 January have been deferred until further notice, i.e., phase 3 (wholesalers to investigate alerts on returned packs) and phase 4 (red/amber/green colours switched on in FMD software for pharmacies and hospitals). See table......READ MORE
